Global Bronchodilators Market to Reach $45 Billion by 2030
The global market for Bronchodilators estimated at US$32.7 Billion in the year 2023, is expected to reach US$45 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Bronchodilators for Asthma, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$19.1 Billion by the end of the analysis period. Growth in the Bronchodilators for Chronic Obstructive Pulmonary Disease segment is estimated at 4.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $8.8 Billion, While China is Forecast to Grow at 7.9% CAGR
The Bronchodilators market in the U.S. is estimated at US$8.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.7 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.9% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$6.1 Billion by the year 2030.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook